Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCN7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,421
Award facts
- Contract value 100% obligated
- $12,420.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,420.82 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving Defense Health Agency and military healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company maintains an extensive portfolio of pharmaceutical deliveries covering multiple therapeutic domains, from specialty medications to vaccines and medical devices. The current delivery order for Dupixent—a biologic treatment typically used for atopic dermatitis, asthma, and related inflammatory conditions—represents one of numerous small-to-medium value orders fulfilled through this strategic contract vehicle that positions AmerisourceBergen as a key supplier within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCN7B?
SPE2DR26FCN7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCN7B worth?
The government has obligated $12,421 on SPE2DR26FCN7B.
Is contract SPE2DR26FCN7B an order under another contract?
Yes. SPE2DR26FCN7B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCN7B competed?
The extent of competition for SPE2DR26FCN7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award